We are delighted to report Professor Herrling is now officially appointed as NED to the Board. This position had become vacated by Mr Nick Stephens who has now been invited by the Board to take over as Chair. Prof Herrling, Ph.D. was the head of corporate research at...
Mr Nick Stephens first joined Neuro-Bio in Summer 2019 as a Non Executive Director (NED) to the Board, and therefore is very familiar with all aspects of the company from our scientific approach, through to our individual team members. However, following Dr Edward...
The goal of this Conference is to balance molecular advances with translational and clinical research, incorporating social, economic, environmental, and ethical aspects that are critical for the aged. By integrating the multiple aspects of ageing in a single...
We are delighted that, despite the Covid-19 crisis and lab lockdown, we have been able to raise over £1.3m mezzanine B2 funding for the continuation of our pioneering research on Alzheimer’s disease. We are very grateful to our existing investors for their continued...
Neuro-Bio welcomes James Barratt as part of the team. James is studying for a BSc in Pharmacology at Nottingham Trent University, and is currently working as an intern for Neuro-Bio. Neuro-Bio’s novel focus to Alzheimer’s is what encouraged him to apply, along with...
Neuro-Bio welcomes Rosie Barnett as part of the team. Rosie is currently in her third year studying pharmacology as part of her BSc sandwich course at Nottingham Trent University. She has joined the company working as an intern, to gain valuable laboratory experience...
